147 words 12 High quality Altai Neanderthal and Denisovan genomes are revealing which regions of 13 archaic hominin DNA have persisted in the modern human genome. A number of these 14 regions are associated with response to infection and immunity, with a suggestion that 15 derived Neanderthal alleles found in modern Europeans and East Asians may be associated 16 with autoimmunity. Independent sources of DNA-based evidence allow a re-evaluation of 17 the nature and timing of the first epidemiologic transition. By combining skeletal, 18 archaeological and genetic evidence we question whether the first epidemiologic transition 19
pathogens between human species may also have played a role in the extinction of the 23 Neanderthals. 24 
25
Introduction 27 Current models of infectious disease in the Pleistocene tell us little about the pathogens 28 that would have infected Neanderthals (Homo neanderthalensis). If we consider the work of 29 Cockburn 1,2 , Omran 3 , and Barrett 4 , who argue that infectious disease only started to 30 seriously impact human groups after the development of agriculture during the Holocene, 31 we must assume that Neanderthals lived in a time and place largely free of acute infectious 32 disease. The current epidemiologic transition model associates most infectious diseases that 33 cause significant mortality with changing living conditions connected with the rise of 34 agriculture, increased sedentism and higher population densities. As Pleistocene hunter- 35 gatherers, Neanderthals should not be at risk from the "pestilences" of Omran's thesis. 36 However, new genetic evidence has the potential to change our view of Neanderthal 37 pathology, and perhaps even the model of the first epidemiologic transition. 38 Firstly, we must consider the current tools for studying infectious disease in the Pleistocene 39 period. Before the advent of ancient DNA sequencing methods, researchers were limited to 40 studying the skeletal pathologies of humans and Neanderthals from this period (fossilised 41 evidence of bones responding to infection and inflammation). However, only a limited 42 subset of infectious diseases leaves behind these lesions. The publication of high-quality 43 Neanderthal and Denisovan genomes gives us a new opportunity to study Pleistocene 44 infectious disease. Researchers from a range of disciplines interested in the evolution of the 45 modern suite of infectious disease can also draw inferences from this new source of data. As 46 a result of making comparisons between modern humans genomes, seeking genetic 47 polymorphisms which vary in function or frequency between populations, and by also 48 comparing human genomes with high-quality Denisovan and Neanderthal genomes, we are 49 beginning to find evidence of introgressed Neanderthal and Denisovan alleles and 50 haplotypes which have functions in immunity and the response to infection 5-7 . The 51 persistence of these regions of DNA in some modern human genomes suggests they may 52 have conveyed a selective advantage, increasing the fitness of anatomically modern humans 53 (AMH) when dispersing into new environments. Through comparisons of genetic data with 54 skeletal evidence of infection, it is increasingly to analyse which pathogens shaped the 55 evolution of modern humans and their closest relatives. Furthermore, ancient DNA 56 technology now encompasses pathogen DNA, and in the future it may be possible to 57 sequence pathogen DNA directly from Neanderthal remains -including pathogens that do 58 not cause skeletal lesions. The genomes of extant human pathogens are shedding light on 59 the antiquity of these infections in hominins. 60 We will discuss the evidence for infectious disease in Neanderthals, beginning with that of 61 infection-related skeletal pathologies in the archaeological record, and then consider the 62 role of infection in hominin evolution. We have a synthesised current thinking on the 63 chronology of emergence of notable European disease packages (Table 1 ). Finally, we will 64 consider what implications this evidence has for the classical model of the first 65 epidemiologic transition.
66
The Neanderthal Fossil Record 67 Homo neanderthalensis was a large bodied hominin that inhabited Eurasia widely from 68 approximately 250,000 to 28,000 years ago 8 . Neanderthals occupied a hunter-gatherer 69 subsistence niche, forming small bands of approximately 15-30 individuals 8 . Archaeological 70 analysis suggests that while Neanderthal groups were relatively self-sufficient there was 71 some level of exchange and transfer of materials 9 The Neanderthal fossil record of some 400 72 individuals represents one of the largest collections of extinct hominin remains and is larger 73 than that of contemporary Pleistocene Homo sapiens fossils. Genetic estimates for 74 Neanderthal population size vary but agree that total numbers were small. Most studies 75 suggest that the effective population size was between 3000-25000 (peeking around 50KYA 76 before gradual decline) 10-14 . Bocquet-Appel & Degioanni 15 have suggested that the actual 77 population could have theoretically reached 70,000 but agree that the effective population 78 size would have been much smaller due to the impact of environmental and ecological 79 pressures. Thus, the fossil record presents researchers with a broad sample of the whole 80 population. Despite the breadth of skeletal material and the large number of pathological 81 lesions described, the Neanderthals are still viewed as existing in a hunter-gatherer 82 epidemiologic paradigm, an effect of the traditional approach of describing each fossil in 83 relative isolation. Conversely, while systematic population level studies have shown that the 84 Neanderthals sustained high levels of traumatic injury 16,17 , the same methods have largely 85 not been applied to infectious disease. When reviewed as a species there is evidence that 86 along with traumatic injury the Neanderthals displayed a broad range of dental pathology 87 and degenerative diseases as well as a large amount of non-specific infection [18] [19] [20] [21] . 88 From the perspective of the current epidemiologic transition model, the Neanderthals' small 89 group size and limited exchange networks suggests that they could not act as reservoirs for 90 infectious diseases. Also, much has been made of the Neanderthals' apparent lack of 91 cognitive and technological sophistication 22 . There is no logical reason to suppose infectious 92 diseases were unknown to Neanderthal groups based on the fossil evidence. Indeed, the 93 structure of Neanderthal groups would have made disease a potent factor in any 94 demographic collapse related to extinction events 23 . As our understanding of Neanderthal There is also evidence for Neanderthals contributing to the innate immune system in 127 modern Papua New Guinea. A study by Mendez 30 found a haplotype carrying three genes 128 (STAT2, ERBB3, ESYT1) to be absent in Africans, but present at variable frequencies outside 129 Africa, peaking at 54% in Melanesians. The divergence time for the putatively introgressed 130 Melanesian STAT2 haplotype and the Neanderthal STAT2 haplotype is 78kya, compared to a 131 divergence time between the Human Reference Sequence haplotype and Neanderthal 132 haplotype of 609kya. STAT2 is involved in the interferon-alpha response to viral infections, 133 including dengue 33 , influenza and measles 34 . It is of note that STAT2 interacts with other 134 putatively introgressed Neanderthal genes, discussed above: OAS1-3. 135 Sankararaman and colleagues 7 scanned the genomes of modern Europeans and Asians for 136 evidence of individual SNPs that have introgressed from Neanderthals, a number of which 137 have been associated with immunity and auto-immunity in modern humans. One of the It is also important to note that our interpretation of the function of these genetic variants, 164 and our identification of immunity-related variants, replies upon our knowledge of the 165 function of genes and polymorphisms within the human genome, which is incomplete -for 166 example, there may be many more polymorphisms affecting susceptibility to viral, bacterial 167 or fungal infection which we have not yet identified in modern humans, and therefore 168 cannot identify in Neanderthal genetic data. pathogens has led researchers to conclude that many infectious diseases have been co-215 evolving with humans and our ancestors for tens of thousands to millions of years. 216 Furthermore, pathogens that were traditionally thought to be zoonoses acquired from herd 217 animals may in fact be anthroponoses, pathogens humans passed to their animals during 218 the rise of agriculture. 219 It is useful to consider which infectious diseases European Neanderthal populations may 220 have experienced (Table 1) . Pleistocene diseases include pathogens which are found in all 221 primates, and are therefore likely to have co-speciated with Neanderthals (also known as 222 heirloom pathogens); and also those pathogens that phylogenetic evidence suggest predate 223 the Holocene, and are therefore potential Neanderthal pathogens. The same infectious 224 diseases would have affected the first AMH in Europe. They are compared to the diseases 225 associated with the transition to agriculture in the Holocene. 226 Certain pathogens are of particular interest to those studying infectious disease in 227 Neanderthals (see Table 1 ). Kuhn and colleagues 45 speculate that a Pleistocene European 228 rock shelter shows evidence of bedding being burned to eliminate parasites and pests. If 229 Pleistocene European AMH were subject to parasites contaminating their bedding, 230 Neanderthals must have been similarly burdened. There are significant tapeworm reservoirs 231 in African primates that have ancient divergence dates from other species 46 
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